Bethesda, MD – The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Renal Hemodynamics: Integrating with the Nephron and Beyond.
The 2013 FASEB Science Research Conference on “Renal Hemodynamics: Integrating with the Nephron and Beyond” is an important and unique scientific conference that will focus on presentation and discussion of the latest research findings in the area of renal hemodynamic mechanisms that are the cause and consequence of a wide range of disorders including hypertension, diabetes, obesity, metabolic syndrome, glomerular sclerosis and nephropathy.
Held every three years, the 2013 conference format is designed to facilitate presentation and discussion of unpublished research and maximum exchange of novel ideas and hypotheses. The informal setting allows the latest cutting edge research to be used to further our understanding of the physiology and pathophysiology of the kidney.
FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.
In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at SRC@faseb.org
. Proposal guidelines can be found at www.faseb.org/SRC
FASEB is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.